Table 4.
Model | Marker | EFS | OS | ||||
---|---|---|---|---|---|---|---|
HR | 95% CL | p | HR | 95% CL | p | ||
A | SCAs | 0.67 | 0.15−2.91 | 0.59 | 1.06 | 0.16−6.93 | 0.95 |
B | 1 ploss | 0.83 | 0.19−3.63 | 0.80 | 0.38 | 0.07−1.97 | 0.25 |
1 qgain/loss | 1.68 | 0.43−6.53 | 0.46 | 2.45 | 0.56−10.7 | 0.23 | |
3 ploss | 0.95 | 0.26−3.52 | 0.94 | 0.62 | 0.15−2.66 | 0.52 | |
11 qloss | 1.69 | 0.46−6.23 | 0.43 | 2.08 | 0.50−8.74 | 0.32 | |
17 qgain | 0.30 | 0.03−3.52 | 0.34 | 2.59 | 0.26−26.2 | 0.42 |
Multivariate analysis (MVA) showing the hazard ratio (HR) with 95% confidence level (CL), event-free survival (EFS), and overall survival (OS) of segmental chromosomal alterations (SCAs). Model A showing MVA of all SCAs combined (including 1ploss, 1qgain/1qloss, 2pgain, 3ploss, 4ploss, 5ploss, 6qloss, 9ploss, 11qloss, 14qloss, 17ploss, 17qgain, 19qloss, and 22qloss). Model B showing MVA of specific SCAs univariately significant for a lower EFS and OS.